BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19008013)

  • 1. LATS2 tumour specific mutations and down-regulation of the gene in non-small cell carcinoma.
    Strazisar M; Mlakar V; Glavac D
    Lung Cancer; 2009 Jun; 64(3):257-62. PubMed ID: 19008013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells.
    Yao F; Liu H; Li Z; Zhong C; Fang W
    Tumour Biol; 2015 Mar; 36(3):2049-57. PubMed ID: 25391426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.
    Wan L; Sun M; Liu GJ; Wei CC; Zhang EB; Kong R; Xu TP; Huang MD; Wang ZX
    Mol Cancer Ther; 2016 May; 15(5):1082-94. PubMed ID: 26908628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
    Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
    Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC).
    Strazisar M; Mlakar V; Glavac D
    Cell Mol Biol Lett; 2009; 14(3):442-56. PubMed ID: 19238334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HAUSP gene plays an important role in non-small cell lung carcinogenesis through p53-dependent pathways.
    Masuya D; Huang C; Liu D; Nakashima T; Yokomise H; Ueno M; Nakashima N; Sumitomo S
    J Pathol; 2006 Apr; 208(5):724-32. PubMed ID: 16450335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
    Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas.
    Luo SY; Sit KY; Sihoe AD; Suen WS; Au WK; Tang X; Ma ES; Chan WK; Wistuba II; Minna JD; Tsao GS; Lam DC
    Lung Cancer; 2014 Aug; 85(2):282-92. PubMed ID: 24976335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L).
    Ke H; Pei J; Ni Z; Xia H; Qi H; Woods T; Kelekar A; Tao W
    Exp Cell Res; 2004 Aug; 298(2):329-38. PubMed ID: 15265683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.
    Mitsudomi T; Steinberg SM; Nau MM; Carbone D; D'Amico D; Bodner S; Oie HK; Linnoila RI; Mulshine JL; Minna JD
    Oncogene; 1992 Jan; 7(1):171-80. PubMed ID: 1311061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The two single nucleotide polymorphisms in the H37/RBM5 tumour suppressor gene at 3p21.3 correlated with different subtypes of non-small cell lung cancers.
    Oh JJ; Koegel AK; Phan DT; Razfar A; Slamon DJ
    Lung Cancer; 2007 Oct; 58(1):7-14. PubMed ID: 17606309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent polymorphic variations but rare tumour specific mutations of the S100A2 on 1q21 in non-small cell lung cancer.
    Strazisar M; Rott T; Glavac D
    Lung Cancer; 2009 Mar; 63(3):354-9. PubMed ID: 18656279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma.
    Malik SA; Khan MS; Dar M; Hussain MU; Shah MA; Shafi SM; Mudassar S
    Pathol Oncol Res; 2018 Apr; 24(2):207-214. PubMed ID: 28434174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells.
    Deng WG; Kawashima H; Wu G; Jayachandran G; Xu K; Minna JD; Roth JA; Ji L
    Cancer Res; 2007 Jan; 67(2):709-17. PubMed ID: 17234782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinoma.
    Ythier D; Brambilla E; Binet R; Nissou D; Vesin A; de Fraipont F; Moro-Sibilot D; Lantuejoul S; Brambilla C; Gazzeri S; Pedeux R
    Lung Cancer; 2010 Aug; 69(2):180-6. PubMed ID: 19962781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
    Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
    J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pseudogene DUXAP10 promotes an aggressive phenotype through binding with LSD1 and repressing LATS2 and RRAD in non small cell lung cancer.
    Wei CC; Nie FQ; Jiang LL; Chen QN; Chen ZY; Chen X; Pan X; Liu ZL; Lu BB; Wang ZX
    Oncotarget; 2017 Jan; 8(3):5233-5246. PubMed ID: 28029651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients.
    Hatzaki A; Razi E; Anagnostopoulou K; Iliadis K; Kodaxis A; Papaioannou D; Labropoulos S; Vasilaki M; Kosmidis P; Saetta A; Mihalatos M; Nasioulas G
    Mol Cell Probes; 2001 Oct; 15(5):243-7. PubMed ID: 11735295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.
    Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM
    Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.